This is an old revision of this page, as edited by Beetstra (talk | contribs) at 11:46, 16 February 2012 (Saving copy of the {{drugbox}} taken from revid 477128398 of page Ketamine for the Chem/Drugbox validation project (updated: '').). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 11:46, 16 February 2012 by Beetstra (talk | contribs) (Saving copy of the {{drugbox}} taken from revid 477128398 of page Ketamine for the Chem/Drugbox validation project (updated: '').)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)This page contains a copy of the infobox ({{drugbox}}) taken from revid 477128398 of page Ketamine with values updated to verified values. |
Clinical data | |
---|---|
AHFS/Drugs.com | Consumer Drug Information |
Pregnancy category |
|
Dependence liability | Medium |
Routes of administration | IV, IM, Insufflated, oral, topical |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Metabolism | Hepatic, primarily by CYP3A4 |
Elimination half-life | 2.5–3 hours. |
Excretion | renal (>90%) |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
Chemical and physical data | |
Formula | C13H16ClNO |
Molar mass | 237.725 g/mol g·mol |
3D model (JSmol) | |
Melting point | 262 °C (504 °F) |
SMILES
| |
InChI
| |
(verify) |
- Hijazi Y, Boulieu R (2002). "Contribution of CYP3A4, CYP2B6, and CYP2C9 isoforms to N-demethylation of ketamine in human liver microsomes". Drug Metabolism and Disposition. 30 (7): 853–8. doi:10.1124/dmd.30.7.853. PMID 12065445.
{{cite journal}}
: Unknown parameter|month=
ignored (help)